From "Declaration of War" to "Alliance": So-Young and Jin Bo's "Great Reconciliation"
Wallstreetcn·
- In 2024, Jinbo Bio publicly criticized New Oxygen for low-price promotions of its core product, Wei Yi Mei, creating significant market tension.
- Two years later, the companies reversed positions, as New Oxygen formed a partnership with Jinbo Bio and other manufacturers, highlighting shifts in the medical aesthetics industry's power dynamics.
- With increased competition and regulatory approvals for similar products, Jinbo Bio is adapting to a market where traditional pricing power has diminished in favor of downstream sales channels.